Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARMYDA RELOAD-ACS
2011-005449-11Phase 3Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in non–ST-segment elevation acute coronary syndrome (NSTE-ACS), unstable angina, Non-ST-segment elevation myocardial infarction (NSTEMI), sponsored by Università Campus Bio-Medico di Roma. Started Dec 2011; status: active.
02
Drugs
clopidogrel
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)unstable anginaNon-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2011-005449-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005449-11.